He is Director of the Vitrage Activity since February 2014 and since January 1st 2017, he has been appointed Senior Vice President of the Compagnie de Saint-Gobain in charge of the Flat Glass Activity (Innovative Materials Sector*). In January 2012 he has been appointed as General Manager of Saint-Gobain Sekurit activities (Automotive Glazing). He was appointed in 2005 Finance and Plan Director of the Vitrage and High Performance Materials activities, then of the Innovative Materials Sector. ![]() He was also a Director and a member of the Audit and Risk Committee of Essilor between 20, chairing the Audit and Risk Committee from May 2016 to March 2017.īorn in December 1963, Patrick Dupin holds a degree from the Havre Normandie Business school.Īfter having spent several years as a consultant with Coopers & Lybrand (PriceWaterhouseCoopers) and eight years in the Finance Departments of the groups Chargeurs and Matra Telecommunications subsidiaries and divisions in Germany, Patrick Dupin joined Group Saint-Gobain in 1999 as Finance Director within the Abrasives Activity in Germany. In addition, Benoit Bazin has been appointed as Director of Vinci on Jand is, as such, member of the Remuneration Committee and of the Nomination and Corporate Governance Committee. He was appointed Chief Executive Officer as from July 1, 2021. He was appointed Chief Operating Officer of Compagnie de Saint-Gobain on Januand elected to the Board on June 3, 2021. During 2017, he was President and CEO of CertainTeed Corporation in the United States. From 2016 to the end of 2018, Benoit Bazin headed the Construction Products Sector. In 2010, he was named Senior Vice President of Compagnie de Saint-Gobain. From 2009 to the end of 2015, Benoit Bazin headed the Building Distribution Sector. ![]() He held various positions in France and, starting in 2002, in the United States – in a general management role within High-Performance Materials, before taking the Chief Financial Officer role of Compagnie de Saint-Gobain in 2005. These authors contributed equally to this work.After studying in France and in the United States, and spending four years at the Interministerial Committee for Industrial Restructuring (ICIR) and the Treasury Department within the French Ministry of Finance, Benoit Bazin joined Saint-Gobain in 1999. These authors contributed equally to this work. The rest of the authors declare that they have no relevant conflicts of interest. 15152886.6 ie, New compositions and methods of treating and/or preventing chronic obstructive pulmonary disease). Berger has received research support from Nycomed, Takeda, Fondation du Souffle–Fonds de dotation Recherche en Santé Respiratoire, Novartis, Pierre Fabre, Chiesi, Boehringer Ingelheim, AstraZeneca, and GlaxoSmithKline and has a patent pending (EP No. Girodet has received research support from Nycomed, Takeda, Fondation du Souffle–Fonds de dotation Recherche en Santé Respiratoire, Novartis, Pierre Fabre, Almirall, Chiesi, Boehringer Ingelheim, and AstraZeneca and has a patent pending (EP No. ![]() ![]() Dupin has received research support from Nycomed, Takeda, and Fondation du Souffle–Fonds de dotation Recherche en Santé Respiratoire and has a patent pending (EP No. SR2013-021).ĭisclosure of potential conflict of interest: I. Sponsored by Bordeaux University Hospital (ie, CHU de Bordeaux) and supported by 3 grants from Nycomed, Takeda, and Fondation du Souffle–Fonds de dotation Recherche en Santé Respiratoire (grant no.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |